MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis

2015 ◽  
Vol 84 (1) ◽  
pp. 127-133 ◽  
Author(s):  
Wei-Jun Wei ◽  
Chen-Tian Shen ◽  
Hong-Jun Song ◽  
Zhong-Ling Qiu ◽  
Quan-Yong Luo
Author(s):  
Michele Klain ◽  
Carmela Nappi ◽  
Emilia Zampella ◽  
Valeria Cantoni ◽  
Roberta Green ◽  
...  

Abstract Purpose We performed a systematic review and a meta-analysis to investigate the successful ablation rate after radioiodine (RAI) administration in patients with differentiated thyroid cancer (DTC) at intermediate-high risk of recurrence. Methods A comprehensive literature search of the PubMed, Scopus, and Web of Science databases was conducted according to the PRISMA statement. Results The final analysis included 9 studies accounting for 3103 patients at intermediate-high risk of recurrence. In these patients, the successful ablation rates ranged from 51 to 94% with a 71% pooled successful ablation and were higher in intermediate (72%) than in high (52%)-risk patients. Despite the rigorous inclusion standards, a significant heterogeneity among the evaluated studies was observed. Higher administered RAI activities are associated with a lower successful ablation rate in the whole population and in the subgroup of high-risk patients. Furthermore, pooled recurrence rate in intermediate-risk patients achieving successful ablation was only 2% during the subsequent 6.4-year follow-up while the pooled recurrence rate was 14% in patients who did not achieve a successful ablation. Conclusion In a large sample of 3103 patients at intermediate-high risk of persistent/recurrent disease, 71% of patients achieved a successful ablation. In these intermediate-risk patients, the probability of subsequent recurrence is low and most recurrence occurred in those with already abnormal findings at the first control.


Author(s):  
Eunkyung Lee ◽  
Ahn Hwa Young ◽  
Ku Eu Jeong ◽  
Yoo Won Sang ◽  
Nam Kee-Hyun ◽  
...  

Thyroid ◽  
2018 ◽  
Vol 28 (12) ◽  
pp. 1662-1673 ◽  
Author(s):  
Chi Yun Yu ◽  
Omar Saeed ◽  
Alyse S. Goldberg ◽  
Shafaq Farooq ◽  
Rouhi Fazelzad ◽  
...  

2019 ◽  
Vol 98 (3) ◽  
pp. 287-299 ◽  
Author(s):  
Antonio Raffone ◽  
Antonio Travaglino ◽  
Gabriele Saccone ◽  
Massimo Mascolo ◽  
Luigi Insabato ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. e031587 ◽  
Author(s):  
Ernesto Anarte ◽  
Gabriela Ferreira Carvalho ◽  
Annika Schwarz ◽  
Kerstin Luedtke ◽  
Deborah Falla

IntroductionDifferential diagnosis of migraine and cervicogenic headache (CGH) can be challenging given the large overlap of symptoms, commonly leading to misdiagnosis and ineffective treatment. In order to strengthen the differential diagnosis of headache, previous studies have evaluated the utility of physical tests to examine for musculoskeletal impairment, mainly in the cervical spine, which could be provoking or triggering headache. However, no systematic review has attempted to evaluate whether physical tests can differentiate CGH from migraine or both conditions from asymptomatic subjects.Methods/analysisA systematic review protocol has been designed and is reported in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P). A sensitive topic-based search strategy is planned which will include databases, hand searching of key journals and consultation of relevant leading authors in this field. Terms and keywords will be selected after discussion and agreement. Two independent reviewers will perform the search and select studies according to inclusion and exclusion criteria, including any cohort or observational studies evaluating the topic of this review; a third reviewer will confirm accuracy. A narrative synthesis will be developed for all included studies and, if possible, a meta-analysis will be conducted. The overall quality of the evidence will be assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) checklist for diagnostic accuracy studies and the Downs and Black scale for those studies where the QUADAS-2 checklist cannot be applied.Ethics and disseminationEthical approval is not required since no patient information will be collected. The results will provide a deeper understanding about the possibility of using physical tests to differentiate cervicogenic headache from migraine and from asymptomatic subjects, which has direct relevance for clinicians managing people with headache. The results will be published in a peer-reviewed journal and presented at scientific conferences.PROSPERO registration numberCRD42019135269.


Sign in / Sign up

Export Citation Format

Share Document